Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 106,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at https://www.novartis.com.
In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 900 people to serve the evolving needs of patients and the healthcare system, and invests over $30 million in R&D yearly in the country. We pride ourselves in our commitment to diversity and inclusion. We are recognized as a Great Place to Work®, ranked among the Top 50 Best Workplaces™, and are named on the 2022 Best Workplaces™ for Women, for Giving Back and for Hybrid Work in Canada™. For more information visit www.novartis.ca.
Novartis is also proud to support young oncology researchers in Canada. This year Novartis Oncology Young Canadian Investigator Awards - NOYCIA celebrates 20 years providing funding and recognition to oncology researchers who demonstrate excellence in their area of study, during ASCO congress. For more information visit www.noycia.ca.